Transoral Ultrasound Versus no Transoral Ultrasound in Diagnostic Workup of Peritonsillar Abscess
1 other identifier
interventional
368
1 country
3
Brief Summary
Peritonsillar abscess (PTA) is a collection of pus between the palatine tonsil and the constrictor muscle. PTA is detected by recognizing characteristics during clinical examination: redness, pain, malaise, trismus, and unilateral peritonsillar swelling. Clinical assessment, including inspection and palpation, is the traditional diagnostic method for patients suspected of having PTA. If PTA is suspected, aspiration with a large-gauge needle or incision is performed to drain the abscess . It can be challenging to distinguish PTA and peritonsillar cellulitis (PTC) based on clinical examination alone. Due to the increased availability of point-of-care ultrasound, it is a part of the diagnostic workup of PTA. Several studies have shown that transoral US can improve the diagnostic accuracy of patients with a suspected PTA. However, no large multicenter study has evaluated whether one of these methods is superior to the other. It is therefore very clinician-dependent whether the patient will have a transoral US performed or not. The investigators hypothesize that transoral US will increase the diagnostic accuracy of PTA compared to solely clinical examination, which is a visual and palpatory assessment. This will result in fewer unnecessary aspiration attempts and overlooked PTAs. Additionally, the investigators wish to investigate the number of aspirations of transoral US-guided needle aspirations compared to aspirations without ultrasound. Methods This is a cluster randomized study. Patients with suspected PTA will be randomized 1:1 to groups A and B. The cluster randomization will happen weekly using an online randomization tool. Participants are patients refeered to the outpatient clinic on suspicion of a peritonsillar absces. The primary outcome is the diagnostic accuracy The investigators aim to determine whether transoral US is a standard part of the clinical examination by comparing clinical examinations with and without US.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 9, 2025
CompletedFirst Submitted
Initial submission to the registry
January 23, 2026
CompletedFirst Posted
Study publicly available on registry
May 11, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
CompletedMay 11, 2026
April 1, 2026
12 months
January 23, 2026
May 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy
Diagnostic accuracy (sensitivity and specificity) of PTA when performing transoral US and by clinical evaluation. A final PTA diagnosis is defined as pus retriveal on the first visit in the outpatient clinic or follow up visit. No later than four days after inclusion. A final non-PTa diagnosis is defined as disease resolution with conservative treatment
From date of randomization until the treatment is completed, assessed up to 2 months.
Secondary Outcomes (9)
Number of patients undergoing surgery (tons a chaud)
From date of randomization until the treatment is completed, assessed up to 2 months.
Number of positive needle aspirations
Day 1
Number of hospital visits
From date of randomization until the treatment is completed, assessed up to 2 months.
Number of days hospitalized
From date of randomization until the treatment is completed, assessed up to 2 months.
Number of needle aspirations performed
Two measures: At baseline and From date of randomization until the final visit in the outpatient clinic assessed up to 2 months.
- +4 more secondary outcomes
Study Arms (2)
Intervention/clinical investigation with ultrasound
EXPERIMENTALIntervention group Transoral ultrasound A head and neck surgeon, often an ENT resident, will perform the transoral ultrasound. A hockey stick transducer is used for transoral ultrasound diagnostics. The procedure is performed by placing the transducer in a disposable glove filled with ultrasound gel. Transoral ultrasound is initiated by positioning the transducer on the palatoglossal arch and a cranial to caudal sweep of the tonsil.The affected tonsil and its surroundings are scanned. An abscess will appear as a hypoechoic area between the tonsil and the constrictor muscle or inside the tonsil. There will be no flow in an abscess when Color Doppler is applied. The unaffected tonsil and the surrounding area can be scanned as a reference. If randomization is with transoral ultrasound, the aspiration attempts can be performed ultrasound-guided.
Investigation without ultrasound. Control group.
ACTIVE COMPARATORNo ultrasound Standard diagnostic workup and treatment All patients with suspected PTA receive a clinical head and neck examination, including visual inspection of the mouth and throat, and a flexible fiberoptic laryngoscopy (to assess the extent of the abscess in the pharynx and possible edema). If a PTA is suspected, needle aspiration will be performed, followed by relevant antibiotics. Before transoral ultrasound and needle aspiration, a spray of topical anesthetic (lidocaine spray 10 mg/dose) will be applied. In some cases, for example, if the patient has previously had a PTA, an acute tonsillectomy is offered. If the examination does not reveal a PTA, the patients will receive conservative treatment with relevant antibiotics. The patients will be scheduled for a 24-48-hour follow-up if the physician deems it necessary.
Interventions
A small hockey stick ultrasound to scan the oropharynx through the mouth
Eligibility Criteria
You may qualify if:
- Patients referred to the ENT outpatient clinic with a suspected PTA.
- years of age or older.
You may not qualify if:
- Unable to understand the verbal information, participating in research.
- Prior surgical interventions (needle aspiration, surgery, incision) during the course of the disease.
- Compromised airways, needing acute airway management.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Department of Otorhinolaryngology, Head and Neck Surgery & Audiolog
Copenhagen, 2100, Denmark
Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, North Zealand Hospital
Hillerød, Denmark
Department of ORL - Head & Neck Surgery and Audiology, Zealand University Hospital,
Køge, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Professor
Study Record Dates
First Submitted
January 23, 2026
First Posted
May 11, 2026
Study Start
June 9, 2025
Primary Completion
June 1, 2026
Study Completion
July 1, 2026
Last Updated
May 11, 2026
Record last verified: 2026-04